TNXP
Tonix Pharmaceuticals Holding
$10.37
+$0.49 (+4.96%)Jul 27, 2026
Key metrics
The numbers that frame TNXP today
- Market cap
- $165.31M
- P/E (TTM)
- -1.1
- EV / FCF
- 0.1
- Gross margin
- 58.6%
- EV / Sales
- -1.1
- ROIC
- -349.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $9.81
- 52wk High
- $69.97
Growth
Revenue and earnings trend for TNXP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TNXP
Is Tonix Pharmaceuticals Holding a good buy?
No. Tonix Pharmaceuticals Holding has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of TNXP?
Tonix Pharmaceuticals Holding's market capitalization is $165.31M.
What is the P/E ratio for TNXP stock?
Tonix Pharmaceuticals Holding's current P/E ratio is -1.1.
What is the 52-week high for TNXP stock?
The 52-week high for Tonix Pharmaceuticals Holding is $69.97. The current close of $10.37 is 85.2% below that high.
What is the 52-week low for TNXP stock?
The 52-week low for Tonix Pharmaceuticals Holding is $9.81. The current close of $10.37 is 5.7% above that low.
Does TNXP stock pay dividends?
Tonix Pharmaceuticals Holding does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TNXP?
Tonix Pharmaceuticals Holding's Debt / Equity ratio is 0.01.